UnitedHealth Group (NYSE:UNH) Updates FY24 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $27.50-27.75 for the period, compared to the consensus EPS estimate of $27.69. UnitedHealth Group also updated its FY 2024 guidance to 27.500-27.750 EPS.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Barclays boosted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an overweight rating in a research note on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a hold rating to a buy rating and raised their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. TD Cowen raised their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a buy rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an overweight rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 1st. Finally, StockNews.com cut UnitedHealth Group from a buy rating to a hold rating in a research note on Wednesday, September 25th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Buy and a consensus target price of $617.37.

UnitedHealth Group Stock Performance

Shares of UNH opened at $607.55 on Tuesday. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market cap of $561.02 billion, a P/E ratio of 40.29, a P/E/G ratio of 1.66 and a beta of 0.58. The business’s 50 day moving average price is $584.39 and its 200-day moving average price is $532.15.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period last year, the company earned $6.14 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 55.70%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.